Status:

RECRUITING

Evaluation of the Efficacy and Tolerability of an Exclusion Diet in Patients With Juvenile Idiopathic Arthritis

Lead Sponsor:

Meyer Children's Hospital IRCCS

Conditions:

Juvenile Idiopathic Arthritis (JIA)

Eligibility:

All Genders

6-18 years

Phase:

NA

Brief Summary

The JIA-ED study is a pilot project. Based on experience in another inflammatory disease, a 4-week period was extrapolated as sufficient to assess the effectiveness of the experimental intervention. T...

Eligibility Criteria

Inclusion

  • Confirmed diagnosis of juvenile idiopathic arthritis (JIA) in the forms of enthesitis-related arthritis and oligoarticular forms according to the ILAR 2001 criteria (https://medicalcriteria.com/web/reujia/);
  • Age between 6 and 18 years (not yet 18);
  • Active disease of mild to moderate severity, assessed through the Juvenile - Arthritis Disease Activity Score (JADAS10) tool (Trincianti C. et al., American College Rheumatology, 2021);
  • For study groups 2 and 3: failure of ongoing pharmacological therapy at the time of screening, defined as a failure to achieve at least a 20% reduction in JADAS10 values after 3 months of initiating DMARD therapy or biologic medication, or if the disease is inactive on such therapy, a 20% increase in those values;
  • Signed informed consent.

Exclusion

  • Patients requiring systemic immunosuppressive therapy for active uveitis;
  • Patients undergoing therapy with systemic corticosteroids (defined as prednisone equivalent \>0.5 mg/kg for \>7 days) or intra-articular corticosteroids in the 3 months prior to enrollment;
  • Patients with fecal calprotectin values \> 250 mcg/g at the time of screening;
  • Use of antibiotics in the month prior to enrollment.

Key Trial Info

Start Date :

December 12 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 15 2025

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT06874608

Start Date

December 12 2024

End Date

November 15 2025

Last Update

March 13 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

AOU Meyer IRCCS

Florence, Italy, 50139